LOCHEM, Netherlands: In order to be better able to respond to rapidly changing market conditions ForFarmers has taken a fresh look at the basic principles of its Strategy 2025. This review has resulted in five more focused strategic principles whereby the emphasis is on an even more local market approach, differentiation and sustainability-focused innovation of…
Author: Kiran
Cultivated meat company, UPSIDE Foods, gets FDA approval
LONDON, United Kingdom: Agronomics, the leading listed company in cellular agriculture, announced cultivated meat company UPSIDE Foods Inc. has received a ‘No Questions’ letter from the US regulatory body the US Food and Drug Administration (“FDA”), accepting their conclusion that their cultivated chicken is safe to eat. This is a momentous achievement for UPSIDE Foods,…
Ultimate Products launches Salter Origins range in Sainsbury’s Stores
LONDON, United Kingdom: Ultimate Products, the owner of a number of leading homeware brands including Salter and Beldray announced that its newly developed Salter Origins range of sustainable kitchenware items has now launched exclusively in Sainsbury’s stores across the UK, with a wider roll out across other retailers expected to follow in 2023. The Origins…
Lisen Imprinting Diagnostics announces innovative and accurate diagnostic solution for Thyroid Cancer detection
WILMINGTON: Lisen Imprinting Diagnostics (LisenID) announces an innovative and revolutionary epigenetics-based diagnostic method for thyroid cancer detection. The clinical research was published in the Journal of Clinical Oncology (JCO), a high-impact, peer-reviewed medical journal of the American Society of Clinical Oncology (ASCO). The study leverages LisenID’s QCIGISH (Quantitative Chromogenic Imprinted Gene In-Situ Hybridization) technology which…
Poolbeg Pharma led consortium awarded €2.3mn grant funding to progress Oral Vaccine Platform
LONDON, United Kingdom: EncOVac, a consortium led by Poolbeg Pharma, has been awarded €2.3 million in non-dilutive grant funding to progress its Oral Vaccine Platform under the Irish Government’s Disruptive Technologies Innovation Fund (‘DTIF’). Poolbeg Pharma (AIM: POLB) is a clinical stage infectious disease pharmaceutical company. Taking place over three years, the collaboration between Poolbeg…
Antisense Therapeutics CEO, Mark Diamond, announces retirement
SYDNEY, Australia: Antisense Therapeutics Limited (ANP) announced that following his significant tenure as the Company’s Chief Executive Officer and Managing Director (CEO), Mark Diamond has advised that he is retiring as CEO. Mark will continue his responsibilities as CEO until a successor is appointed. ANP Chair, Dr Charmaine Gittleson commented, “On behalf of the ANP…
ForFarmers nominates Theo Spierings as CEO
AMSTERDAM: The supervisory board of ForFarmers N.V. nominates Theo Spierings as member of the Executive Board of ForFarmers for a period of one year, to be appointed by the general shareholders meeting. An extraordinary general meeting of shareholders (‘EGM’) will be convened for this, which is expected to take place in January 2023. Mr Spierings…
Imfinzi recommended for approval in the EU for BTC
LONDON, United Kingdom: AstraZeneca’s Imfinzi (durvalumab) has been recommended for marketing authorisation in the European Union (EU) for the 1st-line treatment of adult patients with unresectable or metastatic biliary tract cancer (BTC) in combination with chemotherapy (gemcitabine plus cisplatin). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency based its…
Enhertu recommended for EU approval for previously treated HER2-positive advanced gastric cancer
LONDON, United Kingdom: AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the treatment of adult patients with advanced HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma who have received a prior trastuzumab-based regimen. Enhertu is a specifically engineered HER2-directed antibody drug conjugate (ADC) being…
Sleep better, Live better
It is safe to speak of a broad social problem: 35% of adults still do not get enough quality sleep. While poor sleep is incredibly harmful to our mental and physical condition Beter Bed has associated itself with a network of experts and develops various initiatives to let the whole of the Netherlands and Belgium…